HCA Holdings Inc (HCA)

HCA (NYSE:Health Services)
$49.01
pos +0.00
+0.00%
Today's Range: 48.10 - 49.22 | HCA Avg Daily Volume: 2,603,600
Last Update: 04/17/14 - 4:00 PM EDT
Volume: 0
YTD Performance: 2.72%
Open: $0.00
Previous Close: $48.57
52 Week Range: $35.20 - $52.83
Oustanding Shares: 440,512,800
Market Cap: 21,748,504,203
6-Month Chart
TheStreet Ratings Grade for HCA
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 13 13 13
Moderate Buy 2 2 2 2
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.34 1.32 1.32 1.32
Latest Dividend: 2.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/13/12
Price Earnings Ratio: 13.79
Price Earnings Comparisons:
HCA Sector Avg. S&P 500
13.79 14.50 29.08
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-4.67% 30.55% 53.25%
GROWTH 12 Mo 3 Yr CAGR
Revenue 3.50 0.11 0.04
Net Income -0.50 0.27 0.08
EPS -3.60 0.24 0.07
Earnings for HCA:
EBITDA 6.38B
Revenue 34.18B
Average Earnings Estimates
Qtr (03/14) Qtr (06/14) FY (12/14) FY (12/15)
Average Estimate $0.85 $0.96 $3.72 $4.36
Number of Analysts 15 14 16 15
High Estimate $1.00 $1.05 $4.18 $5.07
Low Estimate $0.75 $0.87 $3.56 $4.00
Prior Year $0.79 $0.91 $3.41 $3.72
Growth Rate (Year over Year) 7.34% 5.89% 9.18% 17.16%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
In the short term, insurers and providers should continue to benefit from Obamacare.
Bullish
Dec 18, 2013 | 7:50 AM EST
HCA was placed on the Conviction Buy list, according to Goldman Sachs. Company trades at a compelling valuation and has multiple potent...
Bullish
Nov 06, 2013 | 8:27 AM EST
HCA estimates were raised through 2015, Bank of America/Merrill Lynch said. Company is seeing higher sales and margins. Buy rating and ...
Neither side is voting their interests.
Bullish
Sep 18, 2013 | 7:01 AM EDT
HCA was upgraded from Neutral to Buy, Mizuho said. $51 price target. Company should benefit from healthcare reform.   
These stocks all pique my interest at current levels.
This sector is outperforming, and these two names are compelling on a pullback.
Bullish
Dec 18, 2012 | 7:38 AM EST
HCA was initiated with an Overweight rating, JP Morgan said. $39 price target. Company is leveraged to industry reform. 
Update
Dec 13, 2012 | 6:58 AM EST
Oppenheimer Holdings Inc Healthcare Conference (Day 2 of 2) - 12/12/12 - 12/13/12 New York, NY
Now that ‘Obamacare’ is the law of the land, let's revisit some of my old picks in the sector.

Columnist Conversations

The new Fed Chief said this at a recent meeting of the Economic Club of NY ... "We have indeed had a disappoin...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.